7 Things Oncology Clinics Should Check Before Choosing a Pharmaceutical Wholesale Distributor

For an oncology clinic, the supply chain is not a back-office concern. It is part of patient care. The pharmaceutical wholesale distributor you choose determines whether chemotherapy, supportive medications, and specialty products arrive on time, intact, and fully traceable. When a single delayed or compromised shipment can postpone a treatment cycle, distributor selection becomes a clinical decision as much as a commercial one.

Recent history makes the stakes clear. During the 2023 platinum chemotherapy shortage, the large majority of cancer centers reported difficulty obtaining core drugs such as carboplatin and cisplatin. According to a National Comprehensive Cancer Network survey, 93% of academic cancer centers reported a carboplatin shortage that year. Smaller and community clinics, which often order just in time for specific patients, felt the disruption most sharply.

Oncology raises the bar in ways general practice does not. The products are often expensive, temperature-sensitive, hazardous, or subject to restricted distribution. Reimbursement is tight, so buying-and-billing errors carry real financial risk. And treatment schedules leave little room for a late delivery. All of this means your choice of supplier deserves more scrutiny than a routine vendor decision.

This guide outlines seven things every oncology clinic should check before opening an account. Each one targets a specific risk, from cold chain integrity to shortage management, and will help you separate a dependable partner from an ordinary vendor.

7 things to check before choosing a pharmaceutical wholesale distributor

Work through the seven checks below in order. Each looks at a different type of risk, and together they give you a clear, repeatable way to size up any pharmaceutical wholesale distributor.

1. Licensing and accreditation

Every legitimate pharmaceutical wholesale distributor must hold current wholesale distribution licenses for each state it ships into. This is the baseline, and it is non-negotiable. Before a distributor makes your shortlist, verify:

• A current wholesale distribution license for every state they ship into
• License numbers you can confirm with the relevant state board of pharmacy
• NABP Drug Distributor Accreditation (DDA) held at the exact shipping facility

Accreditation adds another layer of assurance. The National Association of Boards of Pharmacy (NABP) runs the Drug Distributor Accreditation (DDA) program, formerly known as VAWD, which is widely viewed as the benchmark for distribution integrity. It is granted at the facility level, so match the exact legal entity and the ship-from address that will serve your clinic.

You can verify accreditation yourself through the NABP accredited-facilities directory. Search for the distributor, then confirm that the specific facility shipping to you is listed and current. A parent company's status does not always match the facility that will actually fill your orders.

For an oncology clinic, verified credentials are the first filter. A distributor that cannot document its licensing does not belong on your shortlist.

2. Oncology and specialty product range

Oncology clinics need far more than common generics. Your pharmaceutical wholesale distributor should carry the chemotherapy agents, supportive care medications, and specialty products your protocols depend on. Ask about catalog depth across the oncology-relevant categories you use most.

Access matters as much as breadth. Some oncology and biologic products move through limited or specialty distribution, so confirm which lines the distributor can actually supply. A partner with a broad, verified manufacturer network is better positioned to keep your regimens stocked.

Biosimilars deserve special attention. As more oncology biosimilars reach the market, a distributor that stocks multiple options gives you flexibility on cost and payer preference. Ask which biosimilar lines are available and how quickly new ones are added to the catalog.

Supportive care is part of the picture too. Antiemetics, growth factors, and pain management products are ordered alongside chemotherapy every day. A partner that lets you consolidate these categories reduces the number of accounts your team has to manage. When you compare wholesale drug distributors, weigh how well each one matches your specific therapeutic mix, not just its total SKU count.

3. Cold chain and hazardous drug handling

Many oncology drugs are temperature-sensitive, and several are classified as hazardous. Handling failures can compromise both product integrity and staff safety. Ask how the distributor stores, monitors, and ships these products.

A strong pharmaceutical wholesale distributor maintains temperature-controlled, monitored warehousing and validated cold chain shipping. It should also follow safe handling and segregation practices for hazardous agents, with documentation you can review. Ask what happens if a shipment is delayed or a temperature excursion occurs. The answer should be a clear, written protocol, not a vague reassurance.

Ask for specifics rather than assurances. A distributor confident in its cold chain will readily share:

• How refrigerated shipments are packed and how the packaging is validated
• How long that packaging holds temperature in transit
• Temperature monitoring you can verify on arrival
• The written protocol for a delay or a temperature excursion

For hazardous and refrigerated oncology products, handling discipline is not optional. It directly protects both patients and clinic staff, and it keeps expensive product from going to waste after a preventable excursion.

4. Drug shortage management and fair allocation

Oncology has lived with recurring drug shortages for years, and the risk has not gone away. A dependable pharmaceutical wholesale distributor plans for shortages before they happen, rather than reacting once shelves are empty.

As recently as late 2025, carboplatin and cisplatin remained among the most problematic of more than twenty chemotherapy drugs in active short supply, based on reporting drawn from FDA shortage data. (Source: U.S. Food and Drug Administration)

Shortages hit smaller clinics hardest. Large health systems can often buy ahead and hold larger reserves, while community centers tend to order just in time for individual patients. That imbalance means a distributor's allocation policy matters enormously for a smaller practice.

Ask any prospective partner how it handles shortages. The right questions include:

• Does it communicate backorders early, with expected restock dates?
• Does it allocate scarce products fairly, based on historical use rather than order size?
• Does it flag substitute options when a product is unavailable?
• Does it participate in fair-allocation approaches during declared shortages?

For a community oncology clinic, a distributor's shortage response can be the difference between staying on protocol and scrambling for alternatives.

5. DSCSA compliance and full traceability

Authenticity is critical in oncology, where counterfeit or diverted product carries serious consequences. The Drug Supply Chain Security Act (DSCSA) governs how pharmaceutical products are traced through the U.S. supply chain, and its enhanced requirements are now fully in effect for wholesale distributors.

As of August 27, 2025, wholesale distributors are required to comply with the DSCSA enhanced drug distribution security requirements enforced by the FDA. (Source: U.S. Food and Drug Administration)

Ask your pharmaceutical wholesale distributor to walk through how it manages serialized product, transaction data, and suspect-product investigations. Reliable wholesale drug distributors provide traceability documentation on request and treat it as routine, not as a special favor.

It also helps to understand your own role. Confirm how transaction information reaches you and how you should verify product on receipt. A distributor that supports your side of the process, rather than leaving you to figure it out, is easier to work with over the long term.

6. Controlled substances, REMS, and documentation

Oncology care often involves controlled substances for pain and supportive therapy, along with products governed by Risk Evaluation and Mitigation Strategies (REMS). Your pharmaceutical wholesale distributor must handle these correctly and consistently.

Confirm that the distributor holds the appropriate DEA registrations and follows suspicious-order monitoring. Ask how it manages REMS-restricted products and maintains chain-of-custody documentation. Clean, auditable records protect your clinic during inspections and reduce compliance risk.

Recalls and returns deserve a clear process too. Oncology products are costly, so ask how the distributor notifies customers of a recall, how quickly it acts, and how it manages returns or replacements. A documented, prompt recall workflow protects both your patients and your budget.

A distributor that treats documentation as a core service, not an afterthought, makes your own compliance far easier to maintain.

7. Ordering technology, delivery reliability, and dedicated support

Oncology clinics frequently order just in time for scheduled treatments, so reliability and visibility are essential. Look for a pharmaceutical wholesale distributor whose ordering platform gives you:

• Real-time order tracking and clear delivery windows
• Online invoice and account access
• Backorder status with expected restock dates
• Integration with your pharmacy or inventory system, where available

Support matters just as much. A single named account manager who understands your ordering patterns is far more useful than a general call center. Ask about delivery cutoffs, emergency ordering, and how quickly issues are resolved when something goes wrong.

Good technology should also give you visibility into what is at risk. Clear backorder status and suggested alternatives let your team plan around a gap instead of discovering it on treatment day.

Among comparable wholesale drug distributors, responsive service and dependable delivery are often the deciding factors for a busy clinic. The right combination of people and technology keeps your schedule moving.

How to compare a pharmaceutical wholesale distributor with a simple scorecard

Turn these seven checks into a scorecard and rate each pharmaceutical wholesale distributor from one to five. Consistent scoring makes it far easier to compare partners side by side, rather than relying on impressions.

Weight the checks that matter most to your clinic, then choose the partner that scores consistently well. A pharmaceutical wholesale distributor that performs across compliance, reliability, and support is usually a safe long-term choice.

Frequently asked questions

What licenses should a pharmaceutical wholesale distributor hold?

At minimum, a distributor should hold valid wholesale distribution licenses for every state it ships into, and it should provide those license numbers on request. Many oncology clinics also look for NABP Drug Distributor Accreditation as an added mark of supply-chain integrity.

How should oncology clinics manage drug shortages with a distributor?

Ask how the distributor communicates backorders and allocates scarce products. Fair allocation based on historical use, rather than order size, helps smaller clinics stay on protocol during shortages like the 2023 platinum crisis.

Why does DSCSA matter when choosing wholesale drug distributors?

DSCSA lets a distributor document where every product came from, which protects your clinic from counterfeit or diverted medications. A compliant distributor provides that traceability as a matter of routine.

Written by the Drugzone Compliance & Distribution Team — pharmaceutical distribution and regulatory specialists supporting oncology clinics, hospitals, and pharmacies across the United States. Last reviewed: August 2026.

Choosing a partner your patients can count on

Selecting a supplier for an oncology clinic is a decision about reliability, safety, and trust. The seven checks above give you a structured way to evaluate any pharmaceutical wholesale distributor before you commit, from credentials and cold chain to shortage response and traceability.

Drugzone Pharmaceuticals Inc. is a nationally licensed, compliance-led distributor supporting oncology clinics, hospitals, pharmacies, and specialty practices across the country. Headquartered in Nanuet, New York, Drugzone pairs verified sourcing, temperature-controlled warehousing, and dedicated account support with nationwide reach — the qualities these seven checks are designed to reveal.

Ready to evaluate your next supply partner? Speak with a distribution specialist or start your application at www.drugzone.com 

Article Author

Binu .B RPH

President

With more than 20 years of experience in the pharmaceutical wholesale sector, I have Founded and managed several companies, including a pharmaceutical wholesale company, a compounding/retail pharmacy,and many more. As the president of Drugzone Pharmaceuticals Inc., I develop new business and maintain existing business relationships.